Upgrade to SI Premium - Free Trial

Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)

May 20, 2024 6:43 AM
Wells Fargo analyst Yanan Zhu reiterated an Overweight rating and $8.00 price target on Autolus Therapeutics plc (NASDAQ: AUTL).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles